MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced that Dr. Shankar Musunuri, Chairman, Chief Executive Officer and Co-Founder and Dr. Huma Qamar, MPH, CMI, Head of Clinical Development and Medical Affairs will participate in an in-person fireside chat moderated by Daniil Gataulin, PhD, Senior Biotech Research Analyst at the Chardan 7th Annual Genetic Medicines Conference being held October 2-3, 2023 in NYC.
Details regarding the fireside chat are as follows:
Date: October 2, 2023
Location: Westin Grand Central, New York, NY
Time: 1:30 p.m. ET
Webcast Link: https://ir.ocugen.com/events/event-details/chardans-7th-annual-genetic-medicines-conference
In addition, Ocugen will conduct one-on-one meetings with registered investors to showcase the Company’s business and clinical development strategy across its unique gene therapy, cell therapy, and vaccine platforms, and highlight recent corporate achievements, including the Company’s recent positive Phase 1/2 OCU400 clinical study update and anticipated milestones.